These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5115851)

  • 21. The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Drewinko B; Novak JK; Barranco SC
    Cancer Res; 1972 Jun; 32(6):1206-8. PubMed ID: 4113143
    [No Abstract]   [Full Text] [Related]  

  • 22. Topical lomustine in the treatment of psoriasis.
    Peck GL; Guss SB; Key DJ
    Arch Dermatol; 1972 Aug; 106(2):172-6. PubMed ID: 4558698
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
    Perloff M; Muggia FM; Ackerman C
    Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
    [No Abstract]   [Full Text] [Related]  

  • 24. Further studies on streptozotocin therapy for a multiple-hormone-producing islet cell carcinoma.
    Murray-Lyon IM; Cassar J; Coulson R; Williams R; Ganguli PC; Edwards JC; Taylor KW
    Gut; 1971 Sep; 12(9):717-20. PubMed ID: 4329097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
    Kinne DW; Humphrey EW
    Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
    Takita H; Brugarolas A; Mittelman A; Vincent R
    Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of mycosis fungoides with topical nitrosourea compounds.
    Zackheim HS
    Arch Dermatol; 1972 Aug; 106(2):177-82. PubMed ID: 5048217
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Oct; 56(5):649-52. PubMed ID: 4119908
    [No Abstract]   [Full Text] [Related]  

  • 29. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms.
    Gailani S; Kutcher J
    J Med; 1973; 4(4):209-18. PubMed ID: 4520348
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas.
    Tormey DC; Gailani S; Leone L
    Oncology; 1974; 29(3):244-8. PubMed ID: 4415043
    [No Abstract]   [Full Text] [Related]  

  • 32. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
    Cohen SM; Weiner MJ; Greenspan EM
    Cancer Chemother Rep; 1972 Dec; 56(6):751-4. PubMed ID: 4660631
    [No Abstract]   [Full Text] [Related]  

  • 33. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG; Laster WR; Andrews CM; Schabel FM
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of streptonigrin (NSC-45383) by continuous intravenous infusion in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Reitemeier RJ
    Cancer Chemother Rep; 1967 Apr; 51(2):73-6. PubMed ID: 6043732
    [No Abstract]   [Full Text] [Related]  

  • 35. Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer.
    Frytak S; Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):405-9. PubMed ID: 1097099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical management of advanced gastrointestinal cancer.
    Moertel C
    Semin Drug Treat; 1973; 3(1):55-68. PubMed ID: 4351814
    [No Abstract]   [Full Text] [Related]  

  • 37. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.
    Hoogstraten B; Gottlieb JA; Caoili E; Tucker WG; Talley RW; Haut A
    Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783
    [No Abstract]   [Full Text] [Related]  

  • 38. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB; Falkson G; van Dyk JJ; van der Merwe AM; Falkson HC
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract]   [Full Text] [Related]  

  • 40. Progress report. Cytotoxic therapy for gastrointestinal carcinoma.
    Prostman TJ
    Gut; 1976 Apr; 17(4):313-22. PubMed ID: 57905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.